Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rotavirus PLUS
- Development stage
- Unknown
- Lead developer
- Boryung Biopharma
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Oral
01
Overview
Rotavirus PLUS is a live-attenuated oral vaccine developed and marketed by Boryung Biopharma for the prevention of rotavirus gastroenteritis in infants. It contains a live-attenuated human rotavirus strain, typically of the G1P[8] genotype, which is the most prevalent cause of severe diarrheal disease in children worldwide. The vaccine works by inducing active immunity, mimicking a natural infection to stimulate the production of neutralizing antibodies (primarily intestinal IgA) and cellular immune responses. This provides protection against subsequent exposure to wild-type rotavirus. It is administered as an oral series starting at 6 weeks of age and is part of Boryung's portfolio of pediatric vaccines in South Korea.
- Brand names
- Rotavirus PLUS
- Other names
- Rotavirus vaccineBoryung rotavirus vaccine
Beyond the preview
Go deeper on Rotavirus PLUS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rotavirus PLUS.